The effect of community-acquired pneumonia on plasma esterases in older people

Citation
K. Abou-hatab et al., The effect of community-acquired pneumonia on plasma esterases in older people, EUR J CL PH, 57(1), 2001, pp. 55-60
Citations number
30
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
ISSN journal
00316970 → ACNP
Volume
57
Issue
1
Year of publication
2001
Pages
55 - 60
Database
ISI
SICI code
0031-6970(200104)57:1<55:TEOCPO>2.0.ZU;2-L
Abstract
Introduction: Pneumonia is a major cause of morbidity and mortality in olde r people. The poor outcome of older pneumonia patients despite treatment is still not understood. Objective: The aim of this study was to examine the effect of community-acq uired pneumonia on enzymes of drug metabolism in older people. Methods: Fifteen patients (median age 67 years) with a clinical and radiolo gical diagnosis of community-acquired pneumonia and 14 healthy volunteers m atched for ae and gender (median age 75 years) were recruited, Plasma activ ities of benzoylcholinesterase, butyrylcholinesterase. acetylcholinesterase and aspirin esterase were determined spectrophotometrically; at three time points in pneumonia patients - within 24 h of admission to hospital, 2 day s later and 10 days later. Monocyte aryl hydrocarbon hydroxylase (AHH) acti vity was determined spectrofluorimetrically at the same time points. Enzyme activities were measured at one time Feint in healthy controls. Results: Mean plasma benzoylcholinesterase activity was significantly lower in pneumonia patients on admission to hospital (mean +/- SEM 848 +/- 100) and after 10 days of treatment (mean +/- SEM 925 +/- 114) than in healthy c ontrols (mean +/- SEM 1333 +/- 84, P < 0.05). Similarly: plasma acetylcholi nesterase activity was significantly lower in pneumonia patients on admissi on (P = 0.007) and after 10 days of treatment (P = 0.01) than in controls. Butyrylcholinesterase activity was lower in pneumonia patients on admission (P = 0.029) than in healthy controls, but improved slightly after treatmen t so there was no longer a significant difference at 10 days compared with controls (P = 0.077). In contrast there were no significant differences in plasma aspirin esterase activity or induced monocyte AHH activity between p neumonia patients and healthy controls. The activities of benzoylcholineste rase (r = -0.536, P = 0.04), butyrylcholinesterase (r = -0.638, P = 0.04), acetylcholinesterase (r = -0.583, P = 0.022) and aspirin esterase (r = -0.6 24, P = 0.013) correlated inversely with the British Thoracic Society pneum onia poor prognostic index. Conclusion: The activities of several esterases are reduced in older pneumo nia patients. Other enzymes including aspirin esterase and induced monocyte AHH activity are unaltered in pneumonia. There was a significant inverse r elationship between the activities of all esterases studied and the British Thoracic Society pneumonia poor prognostic index.